Couling John D sold $468K of DLB

Couling John D (SVP, Entertainment) sold 7,667 shares of Dolby Laboratories, Inc. (DLB) at $61.04 ($0.47M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Couling John D
Published Sep 3, 2026, 11:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but 10b5-1 sales are generally treated as less informative than discretionary sales.

02

Market read

A disclosed insider sale of $468,032.02 under a 10b5-1 plan is unlikely to drive a meaningful repricing without other company-specific news.

03

What to watch

The article does not indicate whether the sale was part of a larger multi-tranche program, nor does it provide context on total insider activity or option exercises that could offset net selling.

Relevance 3/10Novelty 2/10Timing: SEC Form 4 filed 2026-09-03, covering a sale executed 2026-09-01.

Background

The article is an SEC Form 4 insider transaction disclosure for Dolby Laboratories, Inc.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby Laboratories Form 4 shows SVP Couling John D sold 7,667 shares at $61.0450 on 2026-09-01 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is an insider transaction, not an earnings, guidance, or regulatory event. The presence of a 10b5-1 plan reduces interpretability as a new negative signal, and the article provides no accompanying company-specific catalyst.

Market effects

Minimal. Insider sales under 10b5-1 typically do not change sector fundamentals for media/entertainment technology.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with periods of elevated valuation or personal liquidity needs, which some traders may still fade.

Key entities

  • Dolby Laboratories, Inc.

    US-listed company whose insider sale is disclosed via Form 4.

  • Couling John D

    SVP, Entertainment who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.